The company, established in 2012, provides wholesale of an extensive range of food supplements and health-related products which are distributed under brands belonging to the Company and produced at contract manufacturing facilities. The company has been able to steadily raise its turnover and grow the sales to EUR 1m in 2017. What is more, Company has managed to reach one of the highest growths in the industry and be among the top 50 manufacturers by over-the-counter sales value in the country.  The company is seeking additional financing of EUR 102,000 for 4 month-period and will use funds raised in the transaction to restructure warehousing operations and change distributor. Lenders are offered 13,2% annual (1.1% monthly) interest with a monthly amortisation schedule. This is a second loan offered to investors for co-financing with the previous debt of EUR 50,000 repaid in time and without any delays.

There is a number of factors that make co-financing to the Company an attractive opportunity and the main highlights are the following: 

• The management has 6-year long experience in the pharmaceutical industry;
  
• The Company has a track record of growth and profitability;
  
• Personal warranty from the key manager;
  
• The company has just finished raising capital by attracting a new investor;
  
• Excellent previous payment discipline with Capitalia;
  
• New product launches are expected to further boost sales growth.